MIM
KALA icon

MetLife Investment Management’s KALA BIO KALA Stock Holding History

MetLife Investment Management’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8
Closed -$128K – 2325
2020
Q4 		$128K Hold
8
– – ﹤0.01% 2188
2020
Q3 		$141K Hold
8
– – ﹤0.01% 2059
2020
Q2 		$197K Buy
8
+3
+60% +$85K ﹤0.01% 1913
2020
Q1 		$107K Buy
+5
New +$79.9K ﹤0.01% 2031
2018
Q2 		– Sell
-3
Closed -$119K – 2197
2018
Q1 		$119K Buy
+3
New +$114K ﹤0.01% 2133

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's KALA Position: Q1 2021 in Review

MetLife Investment Management sold out of KALA BIO (KALA) in Q1 2021, closing a stake of 8 shares — an estimated $128K sold.

MetLife Investment Management first reported a position in KALA in Q1 2018 and held it in 5 quarters. The position peaked at $197K in Q2 2020. 106 funds tracked by Wall St. Rank hold KALA as of Q1 2021.

  • MetLife Investment Management reported no remaining KALA BIO position as of Q1 2021 after selling out during the quarter.
  • MetLife Investment Management sold 8 KALA BIO shares in Q1 2021, an estimated $128K.
  • MetLife Investment Management first reported a position in KALA BIO in Q1 2018 and held it in 5 quarters.
  • MetLife Investment Management's KALA BIO position peaked at $197K in Q2 2020.
  • 106 funds tracked by Wall St. Rank held KALA BIO as of Q1 2021.

Based on MetLife Investment Management's 13F filing for Q1 2021, filed 14 May 2021.